389
Views
7
CrossRef citations to date
0
Altmetric
Review Articles

Therapeutic effects of icariin and icariside II on diabetes mellitus and its complications

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Albersen, M., M. Kendirci, F. van der Aa, W. J. G. Hellstrom, T. F. Lue, and J. L. Spees. 2012. Multipotent stromal cell therapy for cavernous nerve injury-induced erectile dysfunction. The Journal of Sexual Medicine 9 (2):385–403. doi: 10.1111/J.1743-6109.2011.02556.X.
  • Aljehani, A. A., N. A. Albadr, B. G. Eid, and A. B. Abdel-Naim. 2020. Icariin enhances AMP-activated protein kinase and prevents high fructose and high salt-induced metabolic syndrome in rats. Saudi Pharmaceutical Journal: SPJ: The Official Publication of the Saudi Pharmaceutical Society 28 (11):1309–16. doi: 10.1016/J.JSPS.2020.08.021.
  • Anand Ganapathy, A., V. M. Hari Priya, and A. Kumaran. 2021. Medicinal plants as a potential source of phosphodiesterase-5 inhibitors: A review. Journal of Ethnopharmacology 267:113536. doi: 10.1016/J.JEP.2020.113536.
  • Antoniuk, S., M. Bijata, E. Ponimaskin, and J. Wlodarczyk. 2019. Chronic unpredictable mild stress for modeling depression in rodents: Meta-analysis of model reliability. Neuroscience and Biobehavioral Reviews 99:101–16. doi: 10.1016/J.NEUBIOREV.2018.12.002.
  • Aziz, M. T. A., M. A. A. Wassef, H. H. Ahmed, L. Rashed, S. Mahfouz, M. I. Aly, R. E. Hussein, and M. Abdelaziz. 2014. The role of bone marrow derived-mesenchymal stem cells in attenuation of kidney function in rats with diabetic nephropathy. Diabetology & Metabolic Syndrome 6 (1). doi: 10.1186/1758-5996-6-34.
  • Bae, O. N., J. M. Wang, S. H. Baek, Q. Wang, H. Yuan, and A. F. Chen. 2013. Oxidative stress-mediated thrombospondin-2 upregulation impairs bone marrow-derived angiogenic cell function in diabetes mellitus. Arteriosclerosis, Thrombosis, and Vascular Biology 33 (8):1920–7. doi: 10.1161/ATVBAHA.113.301609/-/DC1.
  • Bai, G. Y., F. Zhou, Y. Hui, Y. d Xu, H. E. Lei, J. X. Pu, and Z. C. Xin. 2014. Effects of icariside II on corpus cavernosum and major pelvic ganglion neuropathy in streptozotocin-induced diabetic rats. International Journal of Molecular Sciences 15 (12):23294–306. doi: 10.3390/IJMS151223294.
  • Balakumar, P., R. Sambathkumar, N. Mahadevan, A. B. Muhsinah, A. Alsayari, N. Venkateswaramurthy, and G. Jagadeesh. 2019. A potential role of the renin-angiotensin-aldosterone system in epithelial-to-mesenchymal transition-induced renal abnormalities: Mechanisms and therapeutic implications. Pharmacological Research 146:104314. doi: 10.1016/J.PHRS.2019.104314.
  • Bao, H., and L. Chen. 2011. Icariin reduces mitochondrial oxidative stress injury in diabetic rat hearts. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 36 (11):1503–7. doi: 10.4268/cjcmm20111121.
  • Bojic, L. A., D. E. Telford, M. D. Fullerton, R. J. Ford, B. G. Sutherland, J. Y. Edwards, C. G. Sawyez, R. Gros, B. E. Kemp, G. R. Steinberg, et al. 2014. PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity. Journal of Lipid Research 55 (7):1254–66. doi: 10.1194/JLR.M046037.
  • Bojunga, J., D. Nowak, P. S. Mitrou, D. Hoelzer, S. Zeuzem, and K. U. Chow. 2004. Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic rats. Diabetologia 47 (12):2072–80. doi: 10.1007/S00125-004-1572-7.
  • Bommer, C., E. Heesemann, V. Sagalova, J. Manne-Goehler, R. Atun, T. Bärnighausen, and S. Vollmer. 2017. The global economic burden of diabetes in adults aged 20-79 years: A cost-of-illness study. The Lancet Diabetes & Endocrinology 5 (6):423–30. doi: 10.1016/S2213-8587(17)30097-9.
  • Bublitz, M., M. Musgaard, H. Poulsen, L. Thøgersen, C. Olesen, B. Schiøtt, J. P. Morth, J. V. Møller, and P. Nissen. 2013. Ion pathways in the sarcoplasmic reticulum Ca2+-ATPase. The Journal of Biological Chemistry 288 (15):10759–65. doi: 10.1074/JBC.R112.436550.
  • Burnett, A. L. 2006. The role of nitric oxide in erectile dysfunction: Implications for medical therapy. Journal of Clinical Hypertension (Greenwich, Conn.) 8 (12 Suppl 4):53–62. doi: 10.1111/J.1524-6175.2006.06026.X.
  • Burns, K. O. 2000. Angiotensin II and its receptors in the diabetic kidney. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation 36 (3):449–67. doi: 10.1053/AJKD.2000.16192.
  • Cai, W. J., J. H. Huang, S. Q. Zhang, B. Wu, P. Kapahi, X. M. Zhang, and Z. Y. Shen. 2011. Icariin and its derivative icariside II extend healthspan via insulin/IGF-1 pathway in C. elegans. PLoS One. 6 (12):e28835. doi: 10.1371/journal.pone.0028835.
  • Cao, Y. F., R. R. He, J. Cao, J. X. Chen, T. Huang, and Y. Liu. 2012. Drug-drug interactions potential of icariin and its intestinal metabolites via inhibition of intestinal UDP-Glucuronosyltransferases. Evidence-Based Complementary and Alternative Medicine: eCAM 2012:395912. doi: 10.1155/2012/395912.
  • Cao, S., B. Li, X. Yi, B. Chang, B. Zhu, Z. Lian, Z. Zhang, G. Zhao, H. Liu, and H. Zhang. 2012. Effects of exercise on AMPK signaling and downstream components to PI3K in rat with type 2 diabetes. PLoS One. 7 (12):e51709. doi: 10.1371/journal.pone.0051709.
  • Castela, Â., and C. Costa. 2016. Molecular mechanisms associated with diabetic endothelial-erectile dysfunction. Nature Reviews. Urology 13 (5):266–74. doi: 10.1038/NRUROL.2016.23.
  • Chan, S. M. H., R. Q. Sun, X. Y. Zeng, Z. H. Choong, H. Wang, M. J. Watt, and J. M. Ye. 2013. Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes 62 (6):2095–105. doi: 10.2337/DB12-1397.
  • Charlton, A., J. Garzarella, K. A. M. Jandeleit-Dahm, and J. C. Jha. 2020. Oxidative stress and inflammation in renal and cardiovascular complications of diabetes. Biology 10 (1):18. doi: 10.3390/biology10010018.
  • Che, D., Z. Fang, L. Yan, J. Du, F. Li, J. Xie, J. Feng, P. Yin, W. Qi, Z. Yang, et al. 2020. Elevated pigment epithelium-derived factor induces diabetic erectile dysfunction via interruption of the Akt/Hsp90β/eNOS complex. Diabetologia 63 (9):1857–71. doi: 10.1007/S00125-020-05147-Y/FIGURES/8.
  • Chen, M., J. Wu, Q. Luo, S. Mo, Y. Lyu, Y. Wei, and J. Dong. 2016. The anticancer properties of herba epimedii and its main bioactive componentsicariin and icariside II. Nutrients 8 (9):563. doi: 10.3390/nu8090563.
  • Cheng, T., T. Sheng, Y. Yi, T. Zhang, and H. Han. 2016. Metabolism profiles of icariin in rats using ultra-high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry and in vitro enzymatic study. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 1033-1034:353–60. doi: 10.1016/J.JCHROMB.2016.09.010.
  • Cheng, X., S. Tan, F. Duan, Q. Yuan, Q. Li, and G. Deng. 2019. Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAM. Breast Cancer (Tokyo, Japan) 26 (6):766–75. doi: 10.1007/S12282-019-00980-5.
  • Cho, N. H., Shaw, J. E. Karuranga, S. Huang, Y. da Rocha Fernandes, J. D. Ohlrogge, A. W, and Malanda, B. 2018. IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice 138:271–81. doi: 10.1016/J.DIABRES.2018.02.023.
  • Cho, N. J., S. H. Sung, H. S. Lee, M. H. Jeon, and Y. C. Kim. 1995. Anti-hepatotoxic activity of icariside II, a constituent of Epimedium koreanum. Archives of Pharmacal Research 18 (4):289–92. doi: 10.1007/BF02976415.
  • Coughlan, K. A., R. J. Valentine, N. B. Ruderman, and A. K. Saha. 2014. AMPK activation: A therapeutic target for type 2 diabetes? Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 7:241–53. doi: 10.2147/DMSO.S43731.
  • Di Filippo, C., R. Marfella, S. Cuzzocrea, E. Piegari, P. Petronella, D. Giugliano, F. Rossi, and M. D’Amico. 2005. Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion. Diabetes 54 (3):803–10. doi: 10.2337/DIABETES.54.3.803.
  • Dillmann, W. H. 2019. Diabetic cardiomyopathy. Circulation Research 124 (8):1160–2. doi: 10.1161/CIRCRESAHA.118.314665.
  • Ding, X., H. Zhao, and C. Qiao. 2022. Icariin protects podocytes from NLRP3 activation by Sesn2-induced mitophagy through the Keap1-Nrf2/HO-1 axis in diabetic nephropathy. Phytomedicine : international Journal of Phytotherapy and Phytopharmacology 99:154005. doi: 10.1016/J.PHYMED.2022.154005.
  • Draznin, B.,V. R. Aroda, G. Bakris, G. Benson, F. M. Brown, R. Freeman, J. Green, E. Huang, D. Isaacs, S. Kahan. 2022. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes—2022. Diabetes Care 45:S46–S59. doi: 10.2337/DC22-S004.
  • Eizirik, D. L., L. Pasquali, and M. Cnop. 2020. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: Different pathways to failure. Nature Reviews. Endocrinology 16 (7):349–62. doi: 10.1038/S41574-020-0355-7.
  • Fish, J. E., M. M. Santoro, S. U. Morton, S. Yu, R. F. Yeh, J. D. Wythe, K. N. Ivey, B. G. Bruneau, D. Y. R. Stainier, and D. Srivastava. 2008. miR-126 regulates angiogenic signaling and vascular integrity. Developmental Cell 15 (2):272–84. doi: 10.1016/J.DEVCEL.2008.07.008.
  • Flyvbjerg, A. 2017. The role of the complement system in diabetic nephropathy. Nature Reviews. Nephrology 13 (5):311–8. doi: 10.1038/NRNEPH.2017.31.
  • Forbes, J. M., and M. E. Cooper. 2013. Mechanisms of diabetic complications. Physiological Reviews 93 (1):137–88. doi: 10.1152/PHYSREV.00045.2011.
  • Fu, L., F. Li, A. Bruckbauer, Q. Cao, X. Cui, R. Wu, H. Shi, B. Xue, and M. B. Zemel. 2015. Interaction between leucine and phosphodiesterase 5 inhibition in modulating insulin sensitivity and lipid metabolism. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 8:227–39. doi: 10.2147/DMSO.S82338.
  • Fu, S., Y. Li, Y. Wu, Y. Yue, and D. Yang. 2020. Icariside II improves myocardial fibrosis in spontaneously hypertensive rats by inhibiting collagen synthesis. The Journal of Pharmacy and Pharmacology 72 (2):227–35. doi: 10.1111/JPHP.13190.
  • Galán, M., M. Kassan, S. K. Choi, M. Partyka, M. Trebak, D. Henrion, and K. Matrougui. 2012. A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus. Hypertension (Dallas, Tex. : 1979) 60 (1):71–80. doi: 10.1161/HYPERTENSIONAHA.112.192500/-/DC1.
  • Gao, L., M. Chen, Y. Ouyang, R. Li, X. Zhang, X. Gao, S. Lin, and X. Wang. 2018. Icaritin induces ovarian cancer cell apoptosis through activation of p53 and inhibition of Akt/mTOR pathway. Life Sciences 202:188–94. doi: 10.1016/J.LFS.2018.03.059.
  • Gao, Y., J. Li, S. Chu, Z. Zhang, N. Chen, L. Li, and L. Zhang. 2020. Ginsenoside Rg1 protects mice against streptozotocin-induced type 1 diabetic by modulating the NLRP3 and Keap1/Nrf2/HO-1 pathways. European Journal of Pharmacology 866:172801. doi: 10.1016/J.EJPHAR.2019.172801.
  • Gao, J., L. Long, F. Xu, L. Feng, Y. Liu, J. Shi, and Q. Gong. 2020. Icariside II, a phosphodiesterase 5 inhibitor, attenuates cerebral ischaemia/reperfusion injury by inhibiting glycogen synthase kinase-3β-mediated activation of autophagy. British Journal of Pharmacology 177 (6):1434–52. doi: 10.1111/BPH.14912.
  • Giacco, F., and M. Brownlee. 2010. Oxidative stress and diabetic complications. Circulation Research 107 (9):1058–70. doi: 10.1161/CIRCRESAHA.110.223545.
  • Gu, S.-J., M. Li, Y.-M. Yuan, Z.-C. Xin, andR.-L. Guan. 2021. A novel flavonoid derivative of icariside II improves erectile dysfunction in a rat model of cavernous nerve injury. Andrology 9 (6):1893–901. doi: 10.1111/andr.13065. PMID: 34106520
  • Gu, Z. F., Zhang, Z. T. Wang, J. Y. Xu, and B. Bin. 2017. Icariin exerts inhibitory effects on the growth and metastasis of KYSE70 human esophageal carcinoma cells via PI3K/AKT and STAT3 pathways. Environmental Toxicology and Pharmacology 54:7–13. doi: 10.1016/J.ETAP.2017.06.004.
  • Guo, Y., C. Wang, M. Jiang, H. Zhu, M. Weng, L. Sun, and Y. Zhang. 2020. Baohuoside I via mTOR Apoptotic Signaling to Inhibit Glioma Cell Growth. Cancer Management and Research 12:11435–44. doi: 10.2147/CMAR.S265803.
  • Guo, Y., H. Zhu, M. Weng, B. Chen, C. Wang, and L. Sun. 2020. Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration. Biomedicine & Pharmacotherapy = Biomedecine & pharmacotherapie 128:110366. doi: 10.1016/J.BIOPHA.2020.110366.
  • Hajiaghaalipour, F., M. Khalilpourfarshbafi, A. Arya, and A. Arya. 2015. Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus. International Journal of Biological Sciences 11 (5):508–24. doi: 10.7150/IJBS.11241.
  • Han, Y., H. W. Jung, and Y. K. Park. 2015. Effects of icariin on insulin resistance via the activation of AMPK pathway in C2C12 mouse muscle cells. European Journal of Pharmacology 758:60–3. doi: 10.1016/J.EJPHAR.2015.03.059.
  • Han, W., Q. Ma, Y. Liu, W. Wu, Y. Tu, L. Huang, Y. Long, W. Wang, H. Yee, Z. Wan, et al. 2019. Huangkui capsule alleviates renal tubular epithelial–mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling. Phytomedicine : international Journal of Phytotherapy and Phytopharmacology 57:203–14. doi: 10.1016/J.PHYMED.2018.12.021.
  • Harding, J. L., M. E. Pavkov, D. J. Magliano, J. E. Shaw, and E. W. Gregg. 2019. Global trends in diabetes complications: A review of current evidence. Diabetologia 62 (1):3–16. doi: 10.1007/S00125-018-4711-2/TABLES/5.
  • Heathcote, H. R., S. J. Mancini, A. Strembitska, K. Jamal, J. A. Reihill, T. M. Palmer, G. W. Gould, and I. P. Salt. 2016. Protein kinase C phosphorylates AMP-activated protein kinase α1 Ser487. The Biochemical Journal 473 (24):4681–97. doi: 10.1042/BCJ20160211.
  • Hong, Y. J., M. H. Jeong, Y. H. Choi, J. A. Song, D. H. Kim, K. H. Lee, F. Yamanaka, M. G. Lee, K. H. Park, D. S. Sim, et al. 2012. Impact of diabetes mellitus on plaque vulnerability and clinical outcome in patients with acute myocardial infarction with plaque rupture. International Journal of Cardiology 154 (2):197–8. doi: 10.1016/J.IJCARD.2011.10.074.
  • Hotamisligil, G. S. 2010. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140 (6):900–17. doi: 10.1016/J.CELL.2010.02.034.
  • Hou, X., H. Zeng, Q.-H. Tuo, D.-F. Liao, and J.-X. Chen. 2015. Apelin gene therapy increases autophagy via activation of sirtuin 3 in diabetic heart. Diabetes Research (Fairfax, Va.) 1 (4):84–91. doi: 10.17140/DROJ-1-115.
  • Hu, Y. W., K. Liu, and M. T. Yan. 2015. [ Effect and mechanism of icariin on myocardial ischemia-reperfusion injury model in diabetes rats]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China Journal of Chinese Materia Medica 40 (21):4234–9. doi: 10.4268/cjcmm20152122.
  • Hu, Y., and X. Ma. 2021. Icariin treatment protects against gentamicin-induced ototoxicity via activation of the AMPK-SIRT3 pathway. Frontiers in Pharmacology 12:620741. doi: 10.3389/FPHAR.2021.620741/PDF.
  • Hu, C., L. Sun, L. Xiao, Y. Han, X. Fu, X. Xiong, X. Xu, Y. Liu, S. Yang, F. Liu, et al. 2015. Insights into the mechanisms involved in the expression and regulation of extracellular matrix proteins in diabetic nephropathy. Current Medicinal Chemistry 22 (24):2858–70. doi: 10.2174/0929867322666150625095407.
  • Hwang, Y. H., H. J. Yang, N. H. Yim, and J. Y. Ma. 2017. Genetic toxicity of Epimedium koreanum Nakai. Journal of Ethnopharmacology 198:87–90. doi: 10.1016/J.JEP.2016.11.050.
  • Inserte, J., V. Hernando, M. Ruiz-Meana, M. Poncelas-Nozal, C. Fernández, L. Agulló, C. Sartorio, Ú. Vilardosa, and D. Garcia-Dorado. 2014. Delayed phospholamban phosphorylation in post-conditioned heart favours Ca2+ normalization and contributes to protection. Cardiovascular Research 103 (4):542–53. doi: 10.1093/CVR/CVU163.
  • Jia, G., M. A. Hill, and J. R. Sowers. 2018. Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity. Circulation Research 122 (4):624–38. doi: 10.1161/CIRCRESAHA.117.311586.
  • Jia, Z., K. Wang, Y. Zhang, Y. Duan, K. Xiao, S. Liu, and X. Ding. 2021. Icariin ameliorates diabetic renal tubulointerstitial fibrosis by restoring autophagy via regulation of the miR-192-5p/GLP-1R pathway. Frontiers in Pharmacology 12:720387. doi: 10.3389/FPHAR.2021.720387/PDF.
  • Jia, G., A. Whaley-Connell, and J. R. Sowers. 2018. Diabetic cardiomyopathy: A hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia 61 (1):21–8. doi: 10.1007/s00125-017-4390-4.
  • Jin, J., H. Wang, X. Hua, D. Chen, C. Huang, and Z. Chen. 2019. An outline for the pharmacological effect of icariin in the nervous system. European Journal of Pharmacology 842:20–32. doi: 10.1016/J.EJPHAR.2018.10.006.
  • Jin, J., X. Wang, X. Zhi, and D. Meng. 2019. Epigenetic regulation in diabetic vascular complications. Journal of Molecular Endocrinology 63 (4):R103–R115. doi: 10.1530/JME-19-0170.
  • Joseph, J. J., and S. H. Golden. 2017. Cortisol dysregulation: The bidirectional link between stress, depression, and type 2 diabetes mellitus. Annals of the New York Academy of Sciences 1391 (1):20–34. doi: 10.1111/NYAS.13217.
  • Kahn, S. E., R. L. Hull, and K. M. Utzschneider. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 (7121):840–6. doi: 10.1038/NATURE05482.
  • Kanwar, Y. S., L. Sun, P. Xie, F. Y. Liu, and S. Chen. 2011. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annual Review of Pathology 6:395–423. doi: 10.1146/ANNUREV.PATHOL.4.110807.092150.
  • Kaur, R., M. Kaur, and J. Singh. 2018. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: Molecular insights and therapeutic strategies. Cardiovascular Diabetology 17 (1):121. doi: 10.1186/S12933-018-0763-3.
  • Kim, M. J., S. H. Bae, J. C. Ryu, Y. Kwon, J. H. Oh, J. Kwon, J. S. Moon, K. Kim, A. Miyawaki, M. G. Lee, et al. 2016. SESN2/sestrin2 suppresses sepsis by inducing mitophagy and inhibiting NLRP3 activation in macrophages. Autophagy 12 (8):1272–91. doi: 10.1080/15548627.2016.1183081.
  • Kim, D. H., H. A. Jung, H. S. Sohn, J. W. Kim, and J. S. Choi. 2017. Potential of icariin metabolites from Epimedium koreanum nakai as antidiabetic therapeutic agents. Molecules, 22 (6):986. doi: 10.3390/molecules22060986.
  • Kim, J. Y., and S. H. Shim. 2019. Epimedium koreanum extract and its flavonoids reduced atherosclerotic risk via suppressing modification of human HDL. Nutrients 11 (5):1110. doi: 10.3390/nu11051110.
  • Komatsu, M., H. Kurokawa, S. Waguri, K. Taguchi, A. Kobayashi, Y. Ichimura, Y. S. Sou, I. Ueno, A. Sakamoto, K. I. Tong, et al. 2010. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nature Cell Biology 12 (3):213–23. doi: 10.1038/NCB2021.
  • Kouidrat, Y., D. Pizzol, T. Cosco, T. Thompson, M. Carnaghi, A. Bertoldo, M. Solmi, B. Stubbs, and N. Veronese. 2017. High prevalence of erectile dysfunction in diabetes: A systematic review and meta-analysis of 145 studies. Diabetic Medicine: A Journal of the British Diabetic Association 34 (9):1185–92. doi: 10.1111/DME.13403.
  • Kubiczkova, L., L. Sedlarikova, R. Hajek, and S. Sevcikova. 2012. TGF-β – An excellent servant but a bad master. Journal of Translational Medicine 10 (1):183. doi: 10.1186/1479-5876-10-183.
  • Kullmann, S., A. Kleinridders, D. M. Small, A. Fritsche, H. U. Häring, H. Preissl, and M. Heni. 2020. Central nervous pathways of insulin action in the control of metabolism and food intake. The Lancet. Diabetes & Endocrinology 8 (6):524–34. doi: 10.1016/S2213-8587(20)30113-3.
  • Lei, H., H. Li, L. Tian, M. Li, Z. Xin, X. Zhang, and R. Guan. 2018. Icariside II ameliorates endothelial dysfunction by regulating the MAPK pathway via miR-126/SPRED1 in diabetic human cavernous endothelial cells. Drug Design, Development and Therapy 12:1743–51. doi: 10.2147/DDDT.S166734.
  • Li, Y. C., X. S. Ding, H. M. Li, and C. Zhang. 2013. Icariin attenuates high glucose-induced type IV collagen and fibronectin accumulation in glomerular mesangial cells by inhibiting transforming growth factor-β production and signalling through G protein-coupled oestrogen receptor 1. Clinical and Experimental Pharmacology & Physiology 40 (9):635–43. doi: 10.1111/1440-1681.12143.
  • Liu, Z. 2013. The vascular endothelium in diabetes and its potential as a therapeutic target. Reviews in Endocrine & Metabolic Disorders 14 (1):1–3. 1. doi: 10.1007/S11154-013-9238-8.
  • Liu, M., Bo, Wang, W. Gao, J. Mei, L. F. Shi, J. Shan, Gong, and Q. Hai. 2020. Icariside II attenuates cerebral ischemia/reperfusion-induced blood-brain barrier dysfunction in rats via regulating the balance of MMP9/TIMP1. Acta Pharmacologica Sinica 41 (12):1547–56. doi: 10.1038/S41401-020-0409-3.
  • Liu, Z. Q., Liu, T. Chen, C. Li, M. Y. Wang, Z. Y. Chen, R. Song, Wei, G. Xiang, Wang, X. Yi, and Luo, D. Q. 2015. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice. Toxicology and Applied Pharmacology 285 (1):61–70. doi: 10.1016/J.TAAP.2015.03.011.
  • Liu, T., H. Xin, W. R. Li, F. Zhou, G. Y. Li, Y. Q. Gong, Z. Z. Gao, X. C. Qin, W. S. Cui, A. W. Shindel, et al. 2011. Effects of icariin on improving erectile function in streptozotocin-induced diabetic rats. The Journal of Sexual Medicine 8 (10):2761–72. doi: 10.1111/J.1743-6109.2011.02421.X.
  • Li, H., Y. Xu, R. Guan, M. Matheu, H. Lei, W. Tian, Z. Gao, G. Lin, Y. Guo, Z. Xin, et al. 2015. Icariside II prevents high-glucose-induced injury on human cavernous endothelial cells through Akt-eNOS signaling pathway. Andrology 3 (2):408–16. doi: 10.1111/ANDR.303.
  • Li, M., Y. Zhang, Y. Cao, D. Zhang, L. Liu, Y. Guo, and C. Wang. 2018. Icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (TXNIP) and suppressing ER stress in C2C12 myotubes. Frontiers in Pharmacology 9 (OCT):1180. doi: 10.3389/FPHAR.2018.01180/PDF.
  • Li, X., Y. Wang, P. Shi, Y. Liu, T. Li, S. Liu, C. Wang, L. Wang, and Y. Cao. 2020. Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function. Experimental and Therapeutic Medicine 19 (4): 8490 doi: 10.3892/ETM.2020.8490.
  • Liu, Y., X. Bi, J. Xiong, W. Han, T. Xiao, X. Xu, and K. Y.-M. Therapy. 2019. MicroRNA-34a promotes renal fibrosis by downregulation of klotho in tubular epithelial cells. Elsevier. Retrieved October 8, 2022, from https://www.sciencedirect.com/science/article/pii/S1525001619300504
  • Lloyd-Jones, D., R. J. Adams, T. M. Brown, M. Carnethon, S. Dai, G. de Simone, T. B. Ferguson, E. Ford, K. Furie, C. Gillespie, et al. 2010. Executive summary: Heart disease and stroke statistics-2010 update: A report from the american heart association. Circulation 121 (7):948–54., doi: 10.1161/CIRCULATIONAHA.109.192667.
  • Lu, Y. F., Y. Y. Xu, F. Jin, Q. Wu, J. S. Shi, and J. Liu. 2014. Icariin Is A PPARα Activator Inducing Lipid Metabolic Gene Expression in Mice. Molecules (Basel, Switzerland) 19 (11):18179–91. doi: 10.3390/MOLECULES191118179.
  • Ma, H., X. He, Y. Yang, M. Li, D. Hao, and Z. Jia. 2011. The genus Epimedium: An ethnopharmacological and phytochemical review. Journal of Ethnopharmacology 134 (3):519–41. doi: 10.1016/J.JEP.2011.01.001.
  • Maiese, K., Z. Chong, and Y. C. Shang. 2007. Mechanistic insights into diabetes mellitus and oxidative stress. Current Medicinal Chemistry 14 (16):1729–38. doi: 10.2174/092986707781058968.
  • Mandala, A., N. Das, S. Bhattacharjee, B. Mukherjee, S. Mukhopadhyay, and S. S. Roy. 2016. Thioredoxin interacting protein mediates lipid-induced impairment of glucose uptake in skeletal muscle. Biochemical and Biophysical Research Communications 479 (4):933–9. doi: 10.1016/J.BBRC.2016.09.168.
  • Mátyás, C., B. T. Németh, A. Oláh, L. Hidi, E. Birtalan, D. Kellermayer, M. Ruppert, S. Korkmaz-Icöz, G. Kökény, E. M. Horváth, et al. 2015. The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus. Cardiovascular Diabetology 14 (1):1–13. doi: 10.1186/S12933-015-0309-X/FIGURES/6.
  • Mazrouei, S., F. Sharifpanah, R. W. Caldwell, M. Franz, A. Shatanawi, J. Muessig, M. Fritzenwanger, P. C. Schulze, and C. Jung. 2019. Regulation of MAP kinase-mediated endothelial dysfunction in hyperglycemia via arginase I and eNOS dysregulation. Biochimica et biophysica Acta. Molecular Cell Research 1866 (9):1398–411. doi: 10.1016/J.BBAMCR.2019.05.004.
  • Merz, K. E., and D. C. Thurmond. 2020. Role of skeletal muscle in insulin resistance and glucose uptake. Comprehensive Physiology 10 (3):785–809. doi: 10.1002/cphy.c190029.
  • Meza, C. A., J. D. la Favor, D. H. Kim, and R. C. Hickner. 2019. Endothelial dysfunction: Is there a hyperglycemia-induced imbalance of NOX and NOS? International Journal of Molecular Sciences 20 (15):3775. doi: 10.3390/ijms20153775.
  • Milne, J. C., P. D. Lambert, S. Schenk, D. P. Carney, J. J. Smith, D. J. Gagne, L. Jin, O. Boss, R. B. Perni, C. B. Vu, et al. 2007. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450 (7170):712–6. doi: 10.1038/NATURE06261.
  • Mirzadeh, Z., C. L. Faber, and M. W. Schwartz. 2022. Central nervous system control of glucose homeostasis: A therapeutic target for type 2 diabetes? Annual Review of Pharmacology and Toxicology 62:55–84. doi: 10.1146/ANNUREV-PHARMTOX-052220-010446.
  • Ni, T., N. Lin, X. Huang, W. Lu, Z. Sun, J. Zhang, H. Lin, J. Chi, and H. Guo. 2020. Icariin Ameliorates diabetic cardiomyopathy through Apelin/Sirt3 signalling to improve mitochondrial dysfunction. Frontiers in Pharmacology 11:256. doi: 10.3389/FPHAR.2020.00256/PDF.
  • Ning, H., M. Albersen, G. Lin, T. F. Lue, and C. S. Lin. 2013. Effects of EdU labeling on mesenchymal stem cells. Cytotherapy 15 (1):57–63. doi: 10.1016/J.JCYT.2012.10.010.
  • Ogihara, T., T. Asano, H. Katagiri, H. Sakoda, M. Anai, N. Shojima, H. Ono, M. Fujishiro, A. Kushiyama, Y. Fukushima, et al. 2004. Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase. Diabetologia 47 (5):794–805. doi: 10.1007/S00125-004-1391-X.
  • Pan, Y., Y. Hong, Q. Y. Zhang, and L. D. Kong. 2013. Impaired hypothalamic insulin signaling in CUMS rats: Restored by icariin and fluoxetine through inhibiting CRF system. Psychoneuroendocrinology 38 (1):122–34. doi: 10.1016/J.PSYNEUEN.2012.05.007.
  • Park, M.-S., S.-J. Kim, F. Forghani, S. M. E. Rahman, J.-H. Eo, J.-B. Eun, and D.-H. Oh. 2011. Antimutagenicity and immuno activity of extracts from Epimedium koreanum nakai containing different icariin quantity. Korean Journal of Food Preservation 18 (6):938–45. doi: 10.11002/kjfp.2011.18.6.938.
  • Peng, H., Y. Luo, and Y. Y.-M. Probes. 2020. lncRNA XIST attenuates hypoxia-induced H9c2 cardiomyocyte injury by targeting the miR-122-5p/FOXP2 axis. Elsevier. Retrieved October 8, 2022, from https://www.sciencedirect.com/science/article/pii/S0890850819304153
  • Pernow, J., A. Kiss, Y. Tratsiakovich, and B. Climent. 2015. Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus. British Journal of Pharmacology 172 (19):4684–98. doi: 10.1111/BPH.13242.
  • Qiao, C., H. Wang, Z. Song, Y. Ding, J. Tao, J. Aa, and X. Ding. 2020. Icariin attenuates diabetic cardiomyopathy and downregulates extracellular matrix proteins in heart tissue of type 2 diabetic rats. Pharmacology 105 (9-10):576–85. doi: 10.1159/000505408.
  • Qiao, C., W. Ye, S. Li, H. Wang, and X. Ding. 2018. Icariin modulates mitochondrial function and apoptosis in high glucose-induced glomerular podocytes through G protein-coupled estrogen receptors. Molecular and Cellular Endocrinology 473:146–55. doi: 10.1016/J.MCE.2018.01.014.
  • Qi, M. Y., Y. H. He, Y. Cheng, Q. Fang, R. Y. Ma, S. J. Zhou, and J. Q. Hao. 2021. Icariin ameliorates streptozocin-induced diabetic nephropathy through suppressing the TLR4/NF-κB signal pathway. Food & Function 12 (3):1241–51. doi: 10.1039/D0FO02335C.
  • Qi, C., X. Mao, Z. Zhang, and H. Wu. 2017. Classification and differential diagnosis of diabetic nephropathy. Journal of Diabetes Research 2017:8637138. doi: 10.1155/2017/8637138.
  • Qi, M.-Y., H.-R. Liu, Y-h Su, S.-Q., and Yu, Kai-Chen. 2011. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats. Journal of Ethnopharmacology 138 (3):731–6. doi: 10.1016/J.JEP.2011.10.015.
  • Reul, J. M. H. M., and F. Holsboer. 2002. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Current Opinion in Pharmacology 2 (1):23–33. doi: 10.1016/S1471-4892(01)00117-5.
  • Ricciardi, C. A., and L. Gnudi. 2021. Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies. Metabolism: clinical and Experimental 124:154890. doi: 10.1016/J.METABOL.2021.154890.
  • Richter, E. A., and M. Hargreaves. 2013. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiological Reviews 93 (3):993–1017. doi: 10.1152/PHYSREV.00038.2012.
  • Ritchie, R. H., and E. Dale Abel. 2020. Basic mechanisms of diabetic heart disease. Circulation Research 126 (11):1501–25. doi: 10.1161/CIRCRESAHA.120.315913.
  • Santoleri, D., and P. M. Titchenell. 2019. Resolving the paradox of hepatic insulin resistance. Cellular and Molecular Gastroenterology and Hepatology 7 (2):447–56. doi: 10.1016/J.JCMGH.2018.10.016.
  • Schmidt, A. M. 2018. Highlighting diabetes – The epidemic continues. Arteriosclerosis, Thrombosis, and Vascular Biology 38 (1):e1–e8. doi: 10.1161/ATVBAHA.117.310221.
  • Sharma, S., V. Khan, A. Najmi, O. Alam, and S. Haque. 2018. Prophylactic treatment with icariin prevents isoproterenol-induced myocardial oxidative stress via nuclear factor-Like 2 activation. Pharmacognosy Magazine 14 (55):227–S236. doi: 10.4103/pm.pm_469_17.
  • Sheikh-Ali, M., S. Sultan, A. R. Alamir, M. J. Haas, and A. D. Mooradian. 2010. Hyperglycemia-induced endoplasmic reticulum stress in endothelial cells. Nutrition (Burbank, Los Angeles County, Calif.) 26 (11-12):1146–50. doi: 10.1016/J.NUT.2009.08.019.
  • Shin, Y.-J., Y. J. Jeon, N. Jung, J.-W. Park, H.-Y. Park, and S.-C. Jung. 2015. Substrate-specific gene expression profiles in different kidney cell types are associated with Fabry disease. Molecular Medicine Reports 12 (4):5049–57. https://www.spandidos-publications.com/mmr/12/4/5049. doi: 10.3892/mmr.2015.4010.
  • Singh, W. R., A. Sharma, H. S. Devi, A. Bhatia, M. R. Patel, and D. Kumar. 2022. Icariin improves cutaneous wound healing in streptozotocin-induced diabetic rats. Journal of Tissue Viability 31 (1):197–206. doi: 10.1016/J.JTV.2021.09.004.
  • Sol, M., J. A. A. M. Kamps, J. van den Born, M. C. van den Heuvel, J. van der Vlag, G. Krenning, and J. L. Hillebrands. 2020. Glomerular endothelial cells as instigators of glomerular sclerotic diseases. Frontiers in Pharmacology 11:573557. doi: 10.3389/FPHAR.2020.573557/PDF.
  • Song, L., Y. Zhou, Y. Zhai, X. Huo, M. Chen, H. Shi, Y. Yu, Y. Zhang, and K. Zhou. 2022. Sub-chronic toxicity of an aqueous extract of Epimedium sagittatum (Sieb. Et Zucc.) Maxim. in rats. Drug and Chemical Toxicology :1–11. doi: 10.1080/01480545.2022.2050749.
  • Tahara, A., J. Tsukada, Y. Tomura, T. Yatsu, and M. Shibasaki. 2008. Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells. Pharmacological Research 57 (2):142–50. doi: 10.1016/J.PHRS.2008.01.003.
  • Talapanti, J., H. Kakumanu, L. Yaidikar, and S. Thakur. 2015. Protective role of icariin against oxidative renal damage in cisplatin induced nephrotoxicity. Impactfactor.Org 7 (1)10–16. http://impactfactor.org/PDF/IJTPR/7/IJTPR
  • Tang, Y., A. Jacobi, C. Vater, L. Zou, X. Zou, and M. Stiehler. 2015. Icariin promotes angiogenic differentiation and prevents oxidative stress-induced autophagy in endothelial progenitor cells. Stem Cells (Dayton, Ohio) 33 (6):1863–77. doi: 10.1002/STEM.2005.
  • Thorve, V. S., A. D. Kshirsagar, N. S. Vyawahare, V. S. Joshi, K. G. Ingale, and R. J. Mohite. 2011. Diabetes-induced erectile dysfunction: Epidemiology, pathophysiology and management. Journal of Diabetes and Its Complications 25 (2):129–36. doi: 10.1016/J.JDIACOMP.2010.03.003.
  • Tian, C., H. Chang, X. La, and J. A. Li. 2017. Wushenziye formula improves skeletal muscle insulin resistance in type 2 diabetes mellitus via PTP1B-IRS1-Akt-GLUT4 signaling pathway. Evidence-Based Complementary and Alternative Medicine: eCAM 2017:4393529. doi: 10.1155/2017/4393529.
  • Tian, W., H. Lei, R. Guan, Y. Xu, H. Li, L. Wang, B. Yang, Z. Gao, and Z. Xin. 2015. Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats. Drug Design, Development and Therapy 9:5147–57. doi: 10.2147/DDDT.S90060.
  • Travers, J. G., F. A. Kamal, J. Robbins, K. E. Yutzey, and B. C. Blaxall. 2016. Cardiac Fibrosis: The Fibroblast Awakens. Circulation Research 118 (6):1021–40. doi: 10.1161/CIRCRESAHA.115.306565.
  • Turban, S., C. Stretton, O. Drouin, C. J. Green, M. L. Watson, A. Gray, F. Ross, L. Lantier, B. Viollet, D. G. Hardie, et al. 2012. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells. The Journal of Biological Chemistry 287 (24):20088–99. doi: 10.1074/JBC.M111.330746.
  • Volpe, A., C. Ye, A. J. Hanley, P. W. Connelly, B. Zinman, and R. Retnakaran. 2020. Changes over time in uric acid in relation to changes in insulin sensitivity, beta-cell function, and glycemia. The Journal of Clinical Endocrinology and Metabolism (3):105. doi: 10.1210/CLINEM/DGZ199.
  • Wada, J., and H. Makino. 2016. Innate immunity in diabetes and diabetic nephropathy. Nature Reviews. Nephrology 12 (1):13–26. doi: 10.1038/NRNEPH.2015.175.
  • Wang, S., A. B. Aurora, B. A. Johnson, X. Qi, J. McAnally, J. A. Hill, J. A. Richardson, R. Bassel-Duby, and E. N. Olson. 2008. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Developmental Cell 15 (2):261–71. doi: 10.1016/J.DEVCEL.2008.07.002.
  • Wang, X., C. Liu, Y. Xu, P. Chen, Y. Shen, Y. Xu, Y. Zhao, W. Chen, X. Zhang, Y. Ouyang, et al. 2017. Combination of mesenchymal stem cell injection with icariin for the treatment of diabetes-associated erectile dysfunction. Plos ONE 12 (3):e0174145. doi: 10.1371/journal.pone.0174145.
  • Wang, T., Lu, J. Shi, L. Chen, G. X. M. X. Y. Su, Q. Mu, Y. Chen, L. Hu, R. Tang, X. Yu, et al. 2020. Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: A nationwide, population-based, prospective cohort study. The Lancet Diabetes & Endocrinology 8 (2):115–24. doi: 10.1016/S2213-8587(19)30425-5.
  • Wang, L., Y. Xu, H. Li, H. Lei, R. Guan, Z. Gao, and Z. Xin. 2015. Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats. Journal of Cellular and Molecular Medicine 19 (5):960–9. doi: 10.1111/JCMM.12480.
  • Wang, X., W. Yao, Z. Pan, J. Dong, S. Liu, and X. Ding. 2022. Protective effects and mechanism of icariin against vascular function in diabetic mice. Journal of China Pharmaceutical University 53 (2):215–21.
  • Wang, K., X. Zheng, Z. Pan, W. Yao, X. Gao, X. Wang, and X. Ding. 2020. Icariin prevents extracellular matrix accumulation and ameliorates experimental diabetic kidney disease by inhibiting oxidative stress via GPER mediated p62-dependent Keap1 degradation and Nrf2 activation. Frontiers in Cell and Developmental Biology 8:559. doi: 10.3389/FCELL.2020.00559/PDF.
  • Wang, S., J. Dong, and L. Huang. 2021. Cytokine polymorphisms and predisposition to diabetic nephropathy: A meta-Analysis. International Archives of Allergy and Immunology 182(2):158–65. https://www.karger.com/Article/Abstract/510250
  • Warren, A. M., S. T. Knudsen, and M. E. Cooper. 2019. Diabetic nephropathy: An insight into molecular mechanisms and emerging therapies. Expert Opinion on Therapeutic Targets 23 (7):579–91. doi: 10.1080/14728222.2019.1624721.
  • Wu, M., X. Huang, D. Yan, H. Pan, F. Li, M. Ren, J. Zhang, and M. Xu. 2020. Interactions among endotoxin, uric acid, and lactate in relation to the risk of type 2 diabetes: A population-based study. Journal of Diabetes 12 (8):605–15. doi: 10.1111/1753-0407.13039.
  • Wu, H., M. Kim, and J. Han. 2016. Icariin metabolism by human intestinal microflora. Molecules 21 (9):1158. doi: 10.3390/molecules21091158.
  • Wu, J., F. Zuo, J. Du, P. F. Wong, H. Qin, and J. Xu. 2013. Icariside II induces apoptosis via inhibition of the EGFR pathways in A431 human epidermoid carcinoma cells. Molecular Medicine Reports 8 (2):597–602. doi: 10.3892/MMR.2013.1557.
  • Xiang, H., R. Song, J. Ouyang, R. Zhu, Z. Shu, Y. Liu, X. Wang, D. Zhang, J. Zhao, and H. Lu. 2021. Organelle dynamics of endothelial mitochondria in diabetic angiopathy. European Journal of Pharmacology 895:173865. doi: 10.1016/J.EJPHAR.2021.173865.
  • Xin, H., F. Zhou, T. Liu, G.-Y. Li, J. Liu, Z.-Z. Gao, G.-Y. Bai, H. Lu, and Z.-C. Xin. 2012. Icariin ameliorates streptozotocin-induced diabetic retinopathy in vitro and in vivo. International Journal of Molecular Sciences 13 (1):866–78. doi: 10.3390/IJMS13010866.
  • Xu, S. F., T. Jin, Y. F. Lu, L. S. Li, J. Liu, and J. S. Shi. 2014. Effect of icariin on UDP-glucuronosyltransferases in mouse liver. Planta Medica 80 (5):387–92. doi: 10.1055/S-0034-1368265.
  • Xu, Y., H. Lei, R. Guan, Z. Gao, H. Li, L. Wang, Y. Hui, F. Zhou, and Z. Xin. 2014. Prophylactic protective effects and its potential mechanisms of icariside II on streptozotocin induced spermatogenic dysfunction. International Journal of Molecular Sciences 15 (9):16100–13. doi: 10.3390/IJMS150916100.
  • Xu, F., Q. Wu, L. Li, J. Gong, R. Huo, and W. Cui. 2021. Icariside II: Anticancer potential and molecular targets in solid cancers. Frontiers in Pharmacology 12:663776. doi: 10.3389/FPHAR.2021.663776/PDF.
  • Xu, S., J. Yu, J. Zhan, L. Yang, L. Guo, and Y. Xu. 2017. Pharmacokinetics, tissue distribution, and metabolism study of icariin in rat. BioMed Research International 2017:4684962. doi: 10.1155/2017/4684962.
  • Yang, L., C. Peng, J. Xia, W. Zhang, L. Tian, Y. Tian, X. Yang, and Y. Cao. 2018. Effects of icariside II ameliorates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by activating Akt/NOS/NF-κB signaling. Molecular Medicine Reports 17 (3):4099–105. doi: 10.3892/MMR.2017.8342.
  • Yao, W., K. Wang, X. Wang, X. Li, J. Dong, Y. Zhang, and X. Ding. 2021. Icariin ameliorates endothelial dysfunction in type 1 diabetic rats by suppressing ER stress via the PPARα/Sirt1/AMPKα pathway. Journal of Cellular Physiology 236 (3):1889–902. doi: 10.1002/JCP.29972.
  • Yaribeygi, H., F. R. Farrokhi, A. E. Butler, and A. Sahebkar. 2019. Insulin resistance: Review of the underlying molecular mechanisms. Journal of Cellular Physiology 234 (6):8152–61. doi: 10.1002/JCP.27603.
  • Yin, C., Y. Deng, Y. Liu, J. Gao, L. Yan, and Q. Gong. 2018. Icariside II ameliorates cognitive impairments induced by chronic cerebral hypoperfusion by inhibiting the amyloidogenic pathway: Involvement of BDNF/TrkB/CREB signaling and up-regulation of PPARα and PPARγ in rats. Frontiers in Pharmacology 9 (OCT):1211. doi: 10.3389/FPHAR.2018.01211.
  • Yu, L., S. Li, X. Tang, Z. Li, J. Zhang, X. Xue, J. Han, Y. Liu, Y. Zhang, Y. Zhang, et al. 2017. Diallyl trisulfide ameliorates myocardial ischemia–reperfusion injury by reducing oxidative stress and endoplasmic reticulum stress-mediated apoptosis in type 1 diabetic rats: Role of SIRT1 activation. Apoptosis: An International Journal on Programmed Cell Death 2017 2222 (7):942–54. 7 doi: 10.1007/S10495-017-1378-Y.
  • Zang, L., F. Gao, A. Huang, Y. Zhang, Y. Luo, L. Chen, and N. Mao. 2022. Icariin inhibits epithelial mesenchymal transition of renal tubular epithelial cells via regulating the miR-122-5p/FOXP2 axis in diabetic nephropathy rats. Journal of Pharmacological Sciences 148 (2):204–13. doi: 10.1016/J.JPHS.2021.10.002.
  • Zeng, R., Q. Zhou, W. Zhang, X. Fu, Q. Wu, Y. Lu, and J. S.-T. Reports. 2019. Icariin-mediated activation of autophagy confers protective effect on rotenone induced neurotoxicity in vivo and in vitro. Elsevier. Retrieved November 27, 2022, from https://www.sciencedirect.com/science/article/pii/S2214750019301234
  • Zeni, L., A. G. W. Norden, G. Cancarini, and R. J. Unwin. 2017. A more tubulocentric view of diabetic kidney disease. Journal of Nephrology 30 (6):701–17. doi: 10.1007/S40620-017-0423-9.
  • Zhang, J., A. M. Li, B. X. Liu, F. Han, F. Liu, S. P. Sun, X. Li, S. J. Cui, S. Z. Xian, G. Q. Kong, et al. 2013. Effect of icarisid II on diabetic rats with erectile dysfunction and its potential mechanism via assessment of AGEs, autophagy, mTOR and the NO–cGMP pathway. Asian Journal of Andrology 15 (1):143–8. doi: 10.1038/AJA.2011.175.
  • Zhang, J., S. Li, S. Li, S. Zhang, Y. Wang, S. Jin, C. Zhao, W. Yang, Y. Liu, D. Fang, et al. 2020. Effect of icariside II and metformin on penile erectile function, glucose metabolism, reaction oxygen species, superoxide dismutase, and mitochondrial autophagy in type 2 diabetic rats with erectile dysfunction. Translational Andrology and Urology 9 (2):355–66. doi: 10.21037/TAU.2020.02.07.
  • Zhang, T., and F. Qiu. 2020. Icariin protects mouse insulinoma Min6 cell function by activating the PI3K/AKT pathway. Medical Science Monitor 26:e924453-1. doi: 10.12659/MSM.924453.
  • Zhang, L., S. Wang, Y. Li, Y. Wang, C. Dong, and H. Xu. 2021. Cardioprotective effect of icariin against myocardial fibrosis and its molecular mechanism in diabetic cardiomyopathy based on network pharmacology: Role of ICA in DCM. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology 91:153607. doi: 10.1016/J.PHYMED.2021.153607.
  • Zhang, L., T. Wang, B. S. Zhao, J. X. Zhang, S. Yang, C. L. Fan, and P. Li. 2019. Effect of 2″- O-rhamnosyl icariside II, baohuoside I and baohuoside II in herba epimedii on cytotoxicity indices in HL-7702 and HepG2 cells. Molecules 24 (7):1263. doi: 10.3390/molecules24071263.
  • Zhang, L.-C., Z.-B. Wei, and S.-F. Tang. 2020. Knockdown of the long noncoding RNA LUCAT1 inhibits high-glucose-induced epithelial-mesenchymal transition through the miR-199a-5p–ZEB1 axis. BioMed Research International 2020:8895003. https://www.hindawi.com/journals/bmri/2020/8895003/. doi: 10.1155/2020/8895003.
  • Zhang, Y., T. Yamamoto, I. Hisatome, Y. Li, W. Cheng, N. Sun, B. Cai, T. Huang, Y. Zhu, Z. Li, et al. 2013. Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic β cells. Molecular and Cellular Endocrinology 375 (1-2):89–96. doi: 10.1016/J.MCE.2013.04.027.
  • Zhao, S. Y., L. X. Liao, P. F. Tu, W. W. Li, and K. W. Zeng. 2019. Icariin inhibits AGE-induced injury in PC12 cells by directly targeting apoptosis regulator Bax. Oxidative Medicine and Cellular Longevity 2019:7940808. doi: 10.1155/2019/7940808.
  • Zhong, R., Y. Chen, J. Ling, Z. Xia, Y. Zhan, E. Sun, Z. Shi, L. Feng, X. Jia, J. Song, et al. 2019. The Toxicity and metabolism properties of Herba epimedii flavonoids on laval and adult zebrafish. Evidence-Based Complementary and Alternative Medicine : eCAM 2019:3745051. doi: 10.1155/2019/3745051.
  • Zhong, S., J. Ge, and J. Y. Yu. 2018. Icariin prevents cytokine-induced β-cell death by inhibiting NF-κB signaling. Experimental and Therapeutic Medicine 16 (3):2752–62. doi: 10.3892/ETM.2018.6502/DOWNLOAD.
  • Zhou, F., G. Y. Li, Z. Z. Gao, J. Liu, T. Liu, W. R. Li, W. S. Cui, G. Y. Bai, and Z. C. Xin. 2012. The TGF-β1/Smad/CTGF pathway and corpus cavernosum fibrous-muscular alterations in rats with streptozotocin-induced diabetes. Journal of Andrology 33 (4):651–9. doi: 10.2164/JANDROL.111.014456.
  • Zhou, Y., D. D. Murugan, H. Khan, Y. Huang, and W. S. Cheang. 2021. Roles and therapeutic implications of endoplasmic reticulum stress and oxidative stress in cardiovascular diseases. Antioxidants 10 (8):1167. doi: 10.3390/antiox10081167.
  • Zhu, R., H. Liu, C. Liu, L. Wang, R. Ma, B. Chen, L. Li, J. Niu, M. Fu, D. Zhang, et al. 2017. Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety. Pharmacological Research 122:78–89. doi: 10.1016/j.phrs.2017.05.019.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.